We find the first evidence of hemp farms in Central Asia, followed by China, India and, later, Europe.
The emperor of ancient China, Shennong, includes the hemp plant in the world's first medical paper, the chart of the main medicinal plants discovered, calling it a "superior plant". At that time, the Chinese used the whole plant in the medicinal, textile and food industry.
Hemp farming is no longer a novelty in Europe and the doctors of ancient Rome call the plant from which hemp species is derived Cannabis Sativa and describe its various medicinal uses in a work in 5 volumes.
The Endocannabinoid System was discovered as the mechanism responsible for maintaining in optimal parameters of all the functions of the human body (homeostasis).
California becomes the first US state to legalize the use of cannabis for medicinal purposes.
Hemp farming has been authorized in the US and an increasing number of states are adopting regulations towards the consumption of products based on CBD, the most efficient and studied cannabinoid.
CBD has been included in the "novel food" category by the EU bodies, which requires a prior authorization before its commercialization as a food product and supplement.
The consumption of CBD-based products is legal in most states in the US, as for Europe an increasing number of countries are adopting local legislation in accordance with the provisions at the European level.
CBD’s efficiency
Over 3000 studies have analysed the efficiency of CBD for a significant number of diseases, conditions and ailments, like epilepsy, anxiety and depression, insomnia, Alzheimer’s, Parkinson’s, acne and other skin problems, addictions, autism, schizophrenia and cancer.
The integrity of CBD product labels
A new study finds that nearly 60% of CBD products are mislabeled worldwide, so the necessity of product label integrity is more important than ever.
CBD in relation to leading causes of death
Heart diseases and cancer have remained the leading causes of death at the global level for the last 20 years. However, they are now killing more people than ever before. CBD has been studied and proven effective in relation to symptoms of these conditions.
The First CBD-based drug
In 2018 the U.S. Food and Drug Administration approved the first CBD-based drug called Epidiolex, as a solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. In clinical trials, it reduced the number of convulsive seizures by 38% to 44%.
Have Ever Heard of CBD (General Population)
Have Ever Used CBD (General Population)
Interested in learning more about CBD (General Population)
Likely to purchase CBD in next 6 months (CBD Users)
Believe CBD can treat medical conditions (CBD Users)
Just aware of CBD within last year (those aware of CBD)
New Frontier Data
The vast majority of people confuse CBD with marijuana and think that,
following the consumption of CBD oil, they will experience psychoactive effects.
We dismantle this myth by making the distinction between the types of cannabis plant: Cannabis Sativa, Cannabis Indica and Cannabis Rudelis.
There are two species of Cannabis Sativa, respectively the hemp plant and the marijuana plant.
The main difference between the two is given by the different level of CBD and THC in their structure.
The hemp plant contains a large amount of CBD and only traces of THC, while the marijuana plant contains a large amount of THC and only traces of CBD.
In conclusion, we are talking about marijuana in recreational contexts where users are looking for the psychotropic sensation, while hemp is at the complete opposite pole, being studied for its therapeutic properties on the body.
Although we encounter a reluctance of specialists for the
penetration of CBD in the pharmaceutical industry, currently there are studies according to which the effectiveness of CBD has been analysed for a significant number of diseases, conditions and ailments.
From chronic conditions like epilepsy and schizophrenia to mild conditions like acne, CBD can be a key ingredient that accompanies or even replaces traditional treatments.
Moreover, in 2018, the United States of America approved the first CBD-based medicine, Epidiolex, used to treat two severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome.
For more details on CBD studies in relation to various ailments, click HERE.
Cannabidiol (CBD) as a substance is legal in the European Union and does not appear on any list of
controlled, narcotic or dangerous substances. Moreover, there is no study that issues an opinion according to which food products, oils or cosmetics containing CBD are harmful to the body.
On the contrary, the World Health Organization has formulated a positive opinion on this substance and a growing number of countries in Europe are regulating the legal framework for the sale and consumption of CBD-based products.
Subsequently, each country adopted a position regarding the level of tetrahydrocannabinol (THC), the cannabinoid responsible for the psychoactive effect of the cannabis plant. The vast majority of countries that have adopted legislation in the field have provided a maximum of 0.3% THC in the final product.
Each individual body is different in its own way, and when we administer a CBD-based product, in order to obtain the desired results, it is important to take into account several factors such as: weight, tolerance level and history with similar products.
Depending on the metabolism of each person and the rate of absorption in the body, the experience with CBD-based products will be different. Also, there are other factors external to the body such as diet, stress and fatigue that can influence the effectiveness of the product.
Considering the novelty that CBD brings to the medical industry, there are insufficiently
studied and tested products, such as eye drops, aerosols or nose drops.
That is why it is recommended to choose a studied administration method, such as CBD oils, jellies, capsules, patches or personal care products.
Due to the confusion between CBD and marijuana, there is a myth regarding this cannabinoid which states that it might be addictive.
Of course, this statement is false, and the only major cannabinoid that creates addiction after regular consumption, in large quantities, is THC.
Moreover, there are studies that have demonstrated the effectiveness of CBD in the case of alcohol, tobacco or narcotic addicts.
At the same time, the World Health Organization concluded that CBD does not create addiction and is not harmful to the human body.
Once the method of administration is chosen, it is important to consider the criteria based on which you can identify the best product on the market:
Confident in the amazing potential that the hemp plant has in human medicine, a reality supported by the large number of studies evaluating the effectiveness of cannabinoids in various diseases, we are among the first supporters in Europe of natural alternative therapies based on hemp extract.
HempAID’s mission is to produce the highest quality CBD preparations. Our products are tested in research laboratories, having the CBD quality and concentration guaranteed and certified.
EN 
NL
DE
CZ
FR
IT
PL
ES
TR
PT
DK
FI
GR
NO
SE
AT
BE
IE
MX
CY
JP
CN
IL
SK
